TYP-I-INTERFERON-HEMMUNG BEI SYSTEMISCHEM LUPUS ERYTHEMATODES
European patent · EP4058060 · In force
Register entry
- Publication number
- EP4058060
- Application number
- EP20804531
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 11, 2020
- Published
- Sep 21, 2022
- Granted
- Feb 19, 2025
- Protection ends at the latest
- Nov 10, 2040
- Next annual fee due
- Nov 30, 2026
- IPC classes
- A61K 39/395 (2006.01)A61P 37/00 (2006.01)
- Priority
- US 201962933672 P 11.11.2019US 202063031848 P 29.05.2020US 202063089345 P 08.10.2020
- PCT application
- PCT/EP2020/081770 11.11.2020
- PCT publication
- WO2021/094378 20.05.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 31, 2025
Change
Published in Swissreg on 31.12.2025
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Mar 18, 2025
Agent entered
- Representative
- Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex
Published in Swissreg on 18.03.2025
- Feb 19, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 19.02.2025
Parties
Inventor
151 85 Södertälje, SE
151 85 Södertälje, SE
Wilmington, Delaware 19850, US
Wilmington, Delaware 19850, US
New York, NY 10032, US
33076 Bordeaux, FR
Clayton, Victoria 3168, AU
Manchester M13 9PT, GB
Cambridge Cambridgeshire CB2 0AA, GB
Hempstead, NY 11549, US
Seoul 04763, KR
Kitakyushu, 807-8555, JP
Philadelphia, Pennsylvania 19104, US
1007 MB Amsterdam, NL
London WC1E 6JF, GB
Leeds LS7 4SA, GB
Ann Arbor, Michigan 48109-5422, US
Gaithersburg, Maryland 20878, US
La Jolla, California 92037, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.